Richard P. Shank

10.0k total citations · 3 hit papers
93 papers, 8.1k citations indexed

About

Richard P. Shank is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Richard P. Shank has authored 93 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 55 papers in Cellular and Molecular Neuroscience and 21 papers in Organic Chemistry. Recurrent topics in Richard P. Shank's work include Neuroscience and Neuropharmacology Research (46 papers), Ion channel regulation and function (19 papers) and Amino Acid Enzymes and Metabolism (12 papers). Richard P. Shank is often cited by papers focused on Neuroscience and Neuropharmacology Research (46 papers), Ion channel regulation and function (19 papers) and Amino Acid Enzymes and Metabolism (12 papers). Richard P. Shank collaborates with scholars based in United States, Belgium and Sweden. Richard P. Shank's co-authors include Bruce E. Maryanoff, M. H. Aprison, E E Codd, Joseph F. Gardocki, Daniel H. S. Lee, Wolfgang Reimann, Elmar Friderichs, Robert B. Raffa, Susanna J. Dodgson and Graham LeM. Campbell and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Richard P. Shank

93 papers receiving 7.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.

1992 940 citations Robert B. Raffa, Elmar Friderichs et al. Journal of Pharmacology and Experimental Therapeutics profile →
β-Amyloid1–42 Binds to α7 Nicotinic Acetylcholine Receptor with High Affinity

2000 668 citations Hoau-Yan Wang, Daniel H. S. Lee et al. Journal of Biological Chemistry profile →
An Overview of the Preclinical Aspects of Topiramate: Pharmacology, Pharmacokinetics, and Mechanism of Action

2000 542 citations Richard P. Shank, Joseph F. Gardocki et al. Epilepsia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard P. Shank United States	41	3.3k	3.1k	2.1k	1.4k	1.3k	93	8.1k
Salomón Z. Langer France	59	9.4k 2.8×	8.3k 2.7×	2.4k 1.2×	1.5k 1.1×	1.4k 1.1×	242	15.3k
M. J. Rand Australia	43	3.0k 0.9×	3.5k 1.1×	3.4k 1.6×	444 0.3×	624 0.5×	274	9.2k
Frank Porreca United States	56	6.9k 2.1×	6.2k 2.0×	6.0k 2.9×	559 0.4×	976 0.8×	295	12.4k
John R. Fozard Switzerland	44	5.5k 1.7×	5.1k 1.7×	2.4k 1.2×	796 0.6×	802 0.6×	165	11.1k
Anthony J. Trevor United States	34	2.2k 0.6×	1.4k 0.5×	657 0.3×	241 0.2×	1.3k 1.0×	97	6.1k
W. D. M. Paton United Kingdom	39	2.9k 0.9×	2.8k 0.9×	1.4k 0.7×	230 0.2×	1.4k 1.1×	150	7.7k
Shuji Kaneko Japan	55	4.0k 1.2×	3.8k 1.3×	1.9k 0.9×	1.1k 0.8×	1.0k 0.8×	361	10.5k
Gavril W. Pasternak United States	79	14.2k 4.3×	12.3k 4.0×	7.1k 3.4×	599 0.4×	932 0.7×	331	19.8k
Tiziana Mennini Italy	49	3.8k 1.1×	3.0k 1.0×	1.2k 0.6×	458 0.3×	1.0k 0.8×	270	9.3k
J. David Leander United States	40	3.2k 0.9×	2.3k 0.7×	560 0.3×	495 0.4×	610 0.5×	167	5.1k

Countries citing papers authored by Richard P. Shank

Since Specialization

Citations

This map shows the geographic impact of Richard P. Shank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard P. Shank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard P. Shank more than expected).

Fields of papers citing papers by Richard P. Shank

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard P. Shank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard P. Shank. The network helps show where Richard P. Shank may publish in the future.

Co-authorship network of co-authors of Richard P. Shank

This figure shows the co-authorship network connecting the top 25 collaborators of Richard P. Shank. A scholar is included among the top collaborators of Richard P. Shank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard P. Shank. Richard P. Shank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Klinger, Alexandra L., David F. McComsey, Virginia L. Smith‐Swintosky, Richard P. Shank, & Bruce E. Maryanoff. (2006). Inhibition of Carbonic Anhydrase-II by Sulfamate and Sulfamide Groups: An Investigation Involving Direct Thermodynamic Binding Measurements. Journal of Medicinal Chemistry. 49(12). 3496–3500. 30 indexed citations

Ängehagen, Mikael, Elinor Ben‐Menachem, Richard P. Shank, Lars Rönnbäck, & Elisabeth Hansson. (2003). Topiramate modulation of kainate‐induced calcium currents is inversely related to channel phosphorylation level. Journal of Neurochemistry. 88(2). 320–325. 74 indexed citations

Dubinsky, Barry, Anil H. Vaidya, Daniel I. Rosenthal, et al.. (2002). 5-Ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2 a]pyridine-4-N- (2-fluorophenyl)carboxamide (RWJ-51204), a New Nonbenzodiazepine Anxiolytic. Journal of Pharmacology and Experimental Therapeutics. 303(2). 777–790. 20 indexed citations

Dodgson, Susanna J., Richard P. Shank, & Bruce E. Maryanoff. (2000). Topiramate as an Inhibitor of Carbonic Anhydrase Isoenzymes. Epilepsia. 41(s5). S35–S39. 270 indexed citations

Smith, Lucinda, Molly Price-Jones, Jan Egebjerg, et al.. (2000). Effects of Topiramate on Kainate‐ and Domoate‐Activated [¹⁴C]Guanidinium Ion Flux Through GluR6 Channels in Transfected BHK Cells Using Cytostar‐T Scintillating Microplates. Epilepsia. 41(s1). 48–51. 22 indexed citations

Shank, Richard P., Joseph F. Gardocki, Anthony J. Streeter, & Bruce E. Maryanoff. (2000). An Overview of the Preclinical Aspects of Topiramate: Pharmacology, Pharmacokinetics, and Mechanism of Action. Epilepsia. 41(s1). 3–9. 542 indexed citations breakdown →

Wang, Hoau-Yan, Daniel H. S. Lee, Michael R. D’Andrea, et al.. (2000). β-Amyloid1–42 Binds to α7 Nicotinic Acetylcholine Receptor with High Affinity. Journal of Biological Chemistry. 275(8). 5626–5632. 668 indexed citations breakdown →

Lee, Jung, et al.. (2000). Synthesis and structure–activity relationship of novel pyridyl ethers for the nicotinic acetylcholine receptor. Bioorganic & Medicinal Chemistry Letters. 10(10). 1063–1066. 13 indexed citations

Maryanoff, Bruce E., Michael J. Costanzo, Samuel Nortey, et al.. (1998). Structure−Activity Studies on Anticonvulsant Sugar Sulfamates Related to Topiramate. Enhanced Potency with Cyclic Sulfate Derivatives. Journal of Medicinal Chemistry. 41(8). 1315–1343. 94 indexed citations

10.

Mehta, Ashok K. & Richard P. Shank. (1995). Characterization of a benzodiazepine receptor site with exceptionally high affinity for Ro 15-4513 in the rat CNS. Brain Research. 704(2). 289–297. 23 indexed citations

11.

Shank, Richard P., Joseph F. Gardocki, Jeffry L. Vaught, et al.. (1994). Topiramate: Preclinical Evaluation of a Structurally Novel Anticonvulsant. Epilepsia. 35(2). 450–460. 302 indexed citations

12.

Leo, Gregory C., Bernard F. Driscoll, Richard P. Shank, & Elaine E. Kaufman. (1993). Analysis of [1-<sup>13</sup>C]<i>D</i>-Glucose Metabolism in Cultured Astrocytes and Neurons Using Nuclear Magnetic Resonance Spectroscopy. Developmental Neuroscience. 15(3-5). 282–288. 24 indexed citations

13.

Raffa, Robert B., et al.. (1992). Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.. Journal of Pharmacology and Experimental Therapeutics. 260(1). 275–285. 940 indexed citations breakdown →

14.

Shank, Richard P.. (1992). Adenosine 5?-monophosphate transport across the membrane of synaptosomes and myelin. Neurochemical Research. 17(5). 423–430. 3 indexed citations

15.

Shank, Richard P., et al.. (1990). Adenosine Transport by Rat and Guinea Pig Synaptosomes: Basis for Differential Sensitivity to Transport Inhibitors. Journal of Neurochemistry. 55(2). 541–550. 25 indexed citations

16.

Vaught, Jeffry L., et al.. (1990). Pyrroloisoquinoline antidepressants. 3. A focus on serotonin. Journal of Medicinal Chemistry. 33(10). 2793–2797. 65 indexed citations

17.

Martin, Gregory E., et al.. (1989). Activity of aromatic substituted phenylpiperazines lacking affinity for dopamine binding sites in a preclinical test of antipsychotic efficacy. Journal of Medicinal Chemistry. 32(5). 1052–1056. 56 indexed citations

18.

Martin, Gregory E., et al.. (1988). Block of conditioned avoidance responding in the rat by substituted phenylpiperazines. European Journal of Pharmacology. 156(2). 223–229. 19 indexed citations

19.

Shank, Richard P. & Claude F. Baxter. (1975). UPTAKE AND METABOLISM OF GLUTAMATE BY ISOLATED TOAD BRAINS CONTAINING DIFFERENT LEVELS OF ENDOGENOUS AMINO ACIDS. Journal of Neurochemistry. 24(4). 641–646. 15 indexed citations

20.

Shank, Richard P. & M. H. Aprison. (1970). Method for multiple analyses of concentration and specific radioactivity of individual amino acids in nervous tissue extracts. Analytical Biochemistry. 35(1). 136–145. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact